Enhancing chemotherapy response prediction via matched colorectal tumor-organoid gene expression analysis and network-based biomarker selection
Open Access
- 5 January 2025
- journal article
- research article
- Published by Elsevier in Translational Oncology
- Vol. 52, 102238
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Institutes of Health National Cancer Institute
- Sylvester Comprehensive Cancer Center
This publication has 69 references indexed in Scilit:
- Overexpression of HOXB13 predicts poor prognosis in patients with colon cancerAsian Journal of Surgery, 2022
- Redox-sensitive cyclophilin A elicits chemoresistance through realigning cellular oxidative status in colorectal cancerCell Reports, 2021
- Tumor organoids: Opportunities and challenges to guide precision medicineCancer Cell, 2021
- Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug ResponsesCell Reports, 2020
- Incorporating biological structure into machine learning models in biomedicineCurrent Opinion in Biotechnology, 2020
- Organoid Modeling of the Tumor Immune MicroenvironmentCell, 2018
- Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgeryGenes, Chromosomes and Cancer, 2017
- Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer PatientsCell, 2015
- A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal CancerClinical Colorectal Cancer, 2015
- Generation and external validation of a tumor‐derived 5‐gene prognostic signature for recurrence of lymph node‐negative, invasive colorectal carcinomaCancer, 2012